Search
Products
Community
Markets
News
Brokers
More
IN
Get started
Markets
/
USA
/
Corporate bonds
/
RVNC5133129
/
Analysis
Revance Therapeutics, Inc. 1.75% 15-FEB-2027
RVNC5133129
FINRA
RVNC5133129
FINRA
RVNC5133129
FINRA
RVNC5133129
FINRA
Market closed
Market closed
No trades
See on Supercharts
Overview
Analysis
RVNC5133129 analysis
Overview
Coupon
Redemption
Risks
More
Key facts
Issuer
Revance Therapeutics, Inc.
Issue date
Feb 17, 2021
Maturity date
Feb 15, 2027
Outstanding amount
287.50 M
USD
Face value
1,000.00
USD
Minimum denomination
1,000.00
USD
Coupon
1.75% (Fixed)
Yield to maturity
1.87%
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.
Start trial